Romanian Journal of Internal Medicine最新文献

筛选
英文 中文
Peculiar encounter of sarcoidosis and solid pseudopapillary tumor of the pancreas. 胰腺结节病和实性假乳头状瘤的特殊相遇。
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-06-14 Print Date: 2022-06-01 DOI: 10.2478/rjim-2022-0001
Claudia Cobilinschi, Cristian Cobilinschi, Iuliana Trifan, Constantin-Ioan Busuioc, Ruxandra Ionescu, Daniela Opriş-Belinski
{"title":"Peculiar encounter of sarcoidosis and solid pseudopapillary tumor of the pancreas.","authors":"Claudia Cobilinschi,&nbsp;Cristian Cobilinschi,&nbsp;Iuliana Trifan,&nbsp;Constantin-Ioan Busuioc,&nbsp;Ruxandra Ionescu,&nbsp;Daniela Opriş-Belinski","doi":"10.2478/rjim-2022-0001","DOIUrl":"https://doi.org/10.2478/rjim-2022-0001","url":null,"abstract":"<p><p><b>Objective:</b> Current literature indicates a connection between sarcoidosis and malignancy, prompting advanced screening in uncertain cases. Solid pseudopapillary tumors (SPT) of the pancreas are rare entities that can be confirmed by adding imaging results to immunohistochemistry staining. The aim of this article is to describe a rare association of sarcoidosis and SPT.<b>Materials and methods:</b> Case report.<b>Results</b>: A young female patient with no prior medical history presents with shortness of breath and fatigue. The diagnosis of pulmonary and hepatic sarcoidosis is placed upon laboratory and radiographic changes. Intermittent abdominal pain prompts an MRI that shows the presence of a tumoral mass in the tail of the pancreas. Surgical resection of the mass is performed and histological examination indicates a SPT, subsequently confirmed by immunohistochemistry.<b>Conclusion:</b> This is the third reported case of concomitant sarcoidosis and solid pseudopapillary tumor of the pancreas.</p>","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"60 2","pages":"132-137"},"PeriodicalIF":1.9,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39855096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren's syndrome. 抗环瓜氨酸肽抗体阳性的类风湿关节炎由细菌性肺炎引起的干燥综合征患者。
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-06-14 Print Date: 2022-06-01 DOI: 10.2478/rjim-2022-0003
Taro Horino, Mitsuharu Yoshida, Satoshi Inotani, Kazuki Anabuki, Hiroshi Ohnishi, Masahiro Komori, Osamu Ichii, Yoshio Terada
{"title":"Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren's syndrome.","authors":"Taro Horino,&nbsp;Mitsuharu Yoshida,&nbsp;Satoshi Inotani,&nbsp;Kazuki Anabuki,&nbsp;Hiroshi Ohnishi,&nbsp;Masahiro Komori,&nbsp;Osamu Ichii,&nbsp;Yoshio Terada","doi":"10.2478/rjim-2022-0003","DOIUrl":"https://doi.org/10.2478/rjim-2022-0003","url":null,"abstract":"<p><p>A 58-year-old woman with a history of Sjogren's syndrome was admitted to our hospital with cough, decreased right lung breath sounds and arthralgia in both thumbs. Chest computed tomography showed consolidation with air bronchogram in the right lung. Levels of anti-cyclic citrullinated peptide antibody and rheumatoid factor levels were significantly elevated. She was diagnosed with rheumatoid arthritis induced by bacterial organizing pneumonia. Treatment with salazosulfapyridine was added for rheumatoid arthritis and arthralgia gradually improved. This case highlights that respiratory infections could lead to anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis in patients with Sjogren's syndrome.</p>","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"60 2","pages":"127-131"},"PeriodicalIF":1.9,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39869114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Serum uric acid as a predictor of cardio- and cerebro-vascular diseases in maintenance hemodialysis patients. 血清尿酸作为维持性血液透析患者心脑血管疾病的预测因子。
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-06-14 Print Date: 2022-06-01 DOI: 10.2478/rjim-2021-0039
Najmeh Khodabandeh, Elahe Taziki, Toktam Alirezaei
{"title":"Serum uric acid as a predictor of cardio- and cerebro-vascular diseases in maintenance hemodialysis patients.","authors":"Najmeh Khodabandeh,&nbsp;Elahe Taziki,&nbsp;Toktam Alirezaei","doi":"10.2478/rjim-2021-0039","DOIUrl":"https://doi.org/10.2478/rjim-2021-0039","url":null,"abstract":"<p><p><b>Background:</b> Hyperuricemia is associated with an increased risk of cardio-and cerebrovascular disease (CVD) in general population. However, in the hemodialysis (HD) patients, low serum uric acid (SUA) increases the risk of mortality. Considering that CVD is the principal cause of death among maintenance HD patients, the present study aimed to determine the predictive value of SUA for CVD outcome in this population.<b>Methods:</b> In this two-year follow-up prospective study, 205 outpatients under maintenance HD were enrolled from March 2017 to 2020. Patients' demographic data, underlying diseases, and the results of serum tests, as well as two-year follow-up results of CVD events and mortality were recorded.<b>Results:</b> A total of 130 (63%) patients were eligible for analysis; 62.9% were male; mean age of participants was 59±13years. At follow-up, coronary artery disease was observed in 43.2%, peripheral artery disease in 26.5%, and cerebrovascular disease in 20.5%; angiography was required in 52.3% and 4.5% died of CVD. SUA was ≤5.4 mg/dL in 52 patients, 5.5-6.1 mg/dL in 19, and ≥6.2 mg/dL in 59 patients with significant difference based on mean age, sex distribution, occurrence of cerebrovascular disease and cardiovascular mortality (P<0.05). Patients with cerebrovascular disease had a significantly lower SUA levels (P=0.006). Logistic regression showed the significant effect of SUA on the occurrence of cerebrovascular disease (P=0.008).<b>Conclusion:</b> Low SUA can predict two-year incidence of cerebrovascular disease in HD patients. However, SUA levels did not show significant predictive effect on two-year coronary events, peripheral artery disease and cardiovascular mortality.</p>","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"60 2","pages":"115-122"},"PeriodicalIF":1.9,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39672670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant. COVID-19:补体基因变异患者严重血栓性微血管病变的触发因素
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-06-14 Print Date: 2022-06-01 DOI: 10.2478/rjim-2021-0040
Larisa Pinte, Bogdan Marian Sorohan, Zoltán Prohászka, Mihaela Gherghiceanu, Cristian Băicuş
{"title":"COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant.","authors":"Larisa Pinte,&nbsp;Bogdan Marian Sorohan,&nbsp;Zoltán Prohászka,&nbsp;Mihaela Gherghiceanu,&nbsp;Cristian Băicuş","doi":"10.2478/rjim-2021-0040","DOIUrl":"https://doi.org/10.2478/rjim-2021-0040","url":null,"abstract":"<p><p>The evidence regarding thrombotic microangiopathy (TMA) related to Coronavirus Infectious Disease 2019 (COVID-19) in patients with complement gene mutations as a cause of acute kidney injury (AKI) are limited. We presented the case of a 23-year-old male patient admitted with an asymptomatic form of COVID-19, but with uncontrolled hypertension and AKI. Kidney biopsy showed severe lesions of TMA. In evolution patient had persistent microangiopathic hemolytic anemia, decreased level of haptoglobin and increased LDH level. Decreased complement C3 level and the presence of schistocytes were found for the first time after biopsy. Kidney function progressively decreased and the patient remained hemodialysis dependent. Complement work-up showed a heterozygous variant with unknown significance in complement factor I (CFI) c.-13G>A, affecting the 5' UTR region of the gene. In addition, the patient was found to be heterozygous for the complement factor H (CFH) H3 haplotype (involving the rare alleles of c.-331C>T, Q672Q and E936D polymorphisms) reported as a risk factor of atypical hemolytic uremic syndrome. This case of AKI associated with severe TMA and secondary hemolytic uremic syndrome highlights the importance of genetic risk modifiers in the alternative pathway dysregulation of the complement in the setting of COVID-19, even in asymptomatic forms.</p>","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"60 2","pages":"138-142"},"PeriodicalIF":1.9,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39672671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Acute myelogenous leukemia - current recommendations and approaches in molecular-genetic assessment. 急性髓性白血病-分子遗传学评估的当前建议和方法。
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-06-14 Print Date: 2022-06-01 DOI: 10.2478/rjim-2022-0004
Dinnar Yahya, Mari Hachmeriyan, Ilina Micheva, Trifon Chervenkov
{"title":"Acute myelogenous leukemia - current recommendations and approaches in molecular-genetic assessment.","authors":"Dinnar Yahya,&nbsp;Mari Hachmeriyan,&nbsp;Ilina Micheva,&nbsp;Trifon Chervenkov","doi":"10.2478/rjim-2022-0004","DOIUrl":"https://doi.org/10.2478/rjim-2022-0004","url":null,"abstract":"<p><p>Acute myelogenous leukemia is a multi-step hematological malignancy, affecting function, growth, proliferation and cell cycle of myeloid precursors. Overall assessment of patients with the disease requires among everything else, a comprehensive investigation of the genetic basis through various methods such as cytogenetic and molecular-genetic ones. This clarification provides diagnostic refinement and carries prognostic and predictive value in respect of essential therapeutic choices.With this review of the literature, we focus on summarizing the latest recommendations and preferred genetic methods, as well as on emphasizing on their general benefits and limitations. Since none of these methods is actually totipotent, we also aim to shed light over the often-difficult choice of appropriate genetic analyses.</p>","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"60 2","pages":"103-114"},"PeriodicalIF":1.9,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39633418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Stroke risk scores for prediction of mortality and hemorrhages in atrial fibrillation patients 预测房颤患者死亡率和出血的卒中风险评分
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-06-10 DOI: 10.2478/rjim-2022-0009
A. Ivănescu, C. Delcea, G. Dan
{"title":"Stroke risk scores for prediction of mortality and hemorrhages in atrial fibrillation patients","authors":"A. Ivănescu, C. Delcea, G. Dan","doi":"10.2478/rjim-2022-0009","DOIUrl":"https://doi.org/10.2478/rjim-2022-0009","url":null,"abstract":"Abstract Background: Atrial fibrillation (AF) is an emerging epidemic worldwide, responsible for a twofold increase in mortality, independent of other risk factors. Stroke prevention is the cornerstone of AF management. However, oral anticoagulation imposes an increased risk of bleeding. Several risk scores have been developed for estimating both the thromboembolic and the bleeding risks. The aim of the study was to determine the usefulness of different stroke risk scores as predictors of mortality and hemorrhagic events in AF patients. Methods: We retrospectively enrolled 211 AF patients hospitalized in the Cardiology Ward of our tertiary hospital. The primary endpoints were mortality and non-minor bleeding events. The mean follow-up period was 378 days for bleeding events and 5 years and 1 month for mortality. For each patient, we evaluated the following stroke risk scores: CHADS2, CHA2DS2-VASc, R2CHADS2, ABC, ATRIA, GARFIELD. Results: The mean age in our cohort is 66, with a slight predominance of women (52.2%). For a CHA2DS2-VASc ≥ 4 as well as for a score of 2-3, 5-year survival was worse than for patients with a score of 0–1(chi-squared=8.13; p=0.01). Similarly, all subgroups of patients with an ABC <2%, had a worse 5-year survival when compared with an ABC score of ≥2% (chi-squared=12.85; p=0.005). C-statistics show a modest predictive value for mortality, for all stroke scores except Garfield, with similar AUCs, the highest being for CHA2DS2-VASc (AUC 0.656; p=0.0001). CHA2DS2-VASc also correlates with bleeding events, having a good predictive ability (AUC 0.723; 95%CI 0.658–0.782, p=0.001), mildly superior to HAS-BLED (AUC 0.674; 95% CI 0.523–0.825; p = 0.04) and very close to Garfield-bleeding (0.765; 95%CI 0.702–0.80; p=0.0001). Conclusions: CHA2DS2-VASc is comparable to HAS-BLED and Garfield-bleeding in predicting bleeding events in AF patients. CHA2DS2-VASc and ABC correlate directly and consistently with mortality rate. For CHA2DS2-VASc, the AUCs for our endpoints are similar to the ones for stroke prediction, highlighting the potential of extending its applicability to various outcomes.","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"7 1","pages":"182 - 192"},"PeriodicalIF":1.9,"publicationDate":"2022-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82059142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Lung cancer and combined pulmonary fibrosis and emphysema with anti-ARS antibody 肺癌及合并肺纤维化、肺气肿伴抗ars抗体
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-05-22 DOI: 10.2478/rjim-2022-0008
Riho Tanimura, Kengo Nishino, Ryosuke Iwade, Ryo Abe, S. Okauchi, Y. Sasatani, H. Satoh
{"title":"Lung cancer and combined pulmonary fibrosis and emphysema with anti-ARS antibody","authors":"Riho Tanimura, Kengo Nishino, Ryosuke Iwade, Ryo Abe, S. Okauchi, Y. Sasatani, H. Satoh","doi":"10.2478/rjim-2022-0008","DOIUrl":"https://doi.org/10.2478/rjim-2022-0008","url":null,"abstract":"Abstract A 59-year-old man who had smoked for 23 pack-years was admitted to our hospital because of two-month history of back pain. The chest computed tomography scan demonstrated combined pulmonary fibrosis and emphysema (CPFE) and an irregular shaped nodule in the left lower lobe of the lung. A biopsy obtained from samples from subcarinal lymph nodes revealed non-small cell lung cancer. Anti-aminoacyl-tRNA synthetase (ARS) antibody was elevated up to 166 U/mL, although he had no symptoms suggestive connective tissue diseases. It is well known that most of CPFE patients are current or former heavy smokers, and some researchers described the relationship between CPFE and connective tissue diseases. To our best knowledge, this was the first report of lung cancer in patient with anti-ARS antibody-positive CPFE. In some anti-ARS antibody-positive patients, smoking might have a relationship with development of CPFE and lung cancer.","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"24 1","pages":"193 - 196"},"PeriodicalIF":1.9,"publicationDate":"2022-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81971156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pilot study of changes in urinary podocalyxin levels during normal pregnancy and labor 正常妊娠和分娩期间尿足alyxin水平变化的初步研究
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-05-06 DOI: 10.2478/rjim-2022-0007
Ylbe Palacios de Franco, N. Segovia, Ylbe Franco Marx, Rudiona Hoxhaj, Carlos Franco Palacios
{"title":"A pilot study of changes in urinary podocalyxin levels during normal pregnancy and labor","authors":"Ylbe Palacios de Franco, N. Segovia, Ylbe Franco Marx, Rudiona Hoxhaj, Carlos Franco Palacios","doi":"10.2478/rjim-2022-0007","DOIUrl":"https://doi.org/10.2478/rjim-2022-0007","url":null,"abstract":"Abstract Introduction: Increased urinary podocalyxin, a surrogate marker of podocyte detachment, has been shown in preeclampsia and eclampsia, but there is a paucity of data of the effect of normal pregnancy on its urinary excretion. We aimed to describe these changes in this pilot study. Methods: Urine podocalyxin levels were measured in 115 pregnant women. Of these, 12 women were in the second trimester of gestation, 57 in the third trimester and 46 women were in labor. Results: The median [IQR] urinary podocalyxin levels were 0.81 [0.27, 3.68], 0.92 [0.44, 5.49] and 64.7 [30.5, 106.3] ng/mg creatinine in the second trimester, third trimester, and during labor, respectively (p<0.0001). Patients with hematuria during labor had higher levels of urinary podocalyxin (128.6 [79.8, 169.6] ng/mg creatinine. There was a moderate correlation between gestational age and urinary podocalyxin levels (r=0.63, p<0.0001). Conclusion: Urinary podocalyxin levels were low in normal pregnancies and increased significantly during labor and with hematuria.","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"68 1","pages":"160 - 165"},"PeriodicalIF":1.9,"publicationDate":"2022-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85313770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations 无表皮生长因子受体外显子18-21突变的肝细胞癌中表皮生长因子受体的免疫组化表达
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-04-27 DOI: 10.2478/rjim-2022-0006
D. Nikolova, M. Trajkovska, Emilija Nikolovska Trpcevska, A. Eftimov, Rubens Jovanovik, V. Janevska
{"title":"Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations","authors":"D. Nikolova, M. Trajkovska, Emilija Nikolovska Trpcevska, A. Eftimov, Rubens Jovanovik, V. Janevska","doi":"10.2478/rjim-2022-0006","DOIUrl":"https://doi.org/10.2478/rjim-2022-0006","url":null,"abstract":"Abstract Introduction: EGFR targeted therapies, have been proved beneficial for patients with HCC, nevertheless additional research on EGFR immunoexpresion and EGFR mutations is still needed, especially in population in which it has not been done yet. The aim of this study is to evaluate EGFR immunoexpression in HCC without EGFR exons 18–21 mutations and to evaluate its influence on survival in HCC patients in North Macedonia. Methods: We studied 31 cases of HCC for EGFR immunohistochemical expression and EGFR exons 18–21 mutations. The following clinical parameters were analyzed: Hepatitis B and C virus infection, presence of cirrhosis, tumor size, enlarged lymph nodes, metastases, alpha fetoprotein level and overall survival. Presence of the EGFR immunosignal (membranous and cytoplasmic) and the percentage of positive tumor cells in the entire tumor tissue specimen were semi-quantitatively determined. Results: Hepatitis B and C virus infection, tumor size, metastatic disease and EGFR immunoexpression have influence on patient’s survival. No EGFR exons 18–21 mutations were detected in this group of HCCs. EGFR expression of 61%–80% in tumor tissue significantly influenced survival of the patients (p < 0.01). Multiple Cox regression confirmed tumor size of 5–10 cm (p < 0.05), tumor size > 10 cm (p < 0.01) and EGFR expression in range of 61% to 80% (p < 0.05) as independent survival predictors in patients with HCC. Conclusion: EGFR overexpression in range of 61% to 80% was an independent survival predictor in patients with HCC, implying that these patients could benefit from EGFR inhibition. However, the absence of EGFR mutations in exons 18–21 in any of the cases of this study suggest that single drug EGFR targeted therapy in patients with HCC may be insufficient.","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"92 1","pages":"153 - 159"},"PeriodicalIF":1.9,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90711825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of salivary glucose as a screening tool of diabetes mellitus 唾液葡萄糖作为糖尿病筛查工具的验证
IF 1.9
Romanian Journal of Internal Medicine Pub Date : 2022-04-11 DOI: 10.2478/rjim-2022-0005
A. Choudhry, Pradeep Kumar, M. Prasad, T. Mohapatra, Preeti Sharma
{"title":"Validation of salivary glucose as a screening tool of diabetes mellitus","authors":"A. Choudhry, Pradeep Kumar, M. Prasad, T. Mohapatra, Preeti Sharma","doi":"10.2478/rjim-2022-0005","DOIUrl":"https://doi.org/10.2478/rjim-2022-0005","url":null,"abstract":"Abstract Background: Improved prognosis and delay of clinical complications in diabetes mellitus can be ensured by early screening and regular monitoring after diagnosis. This requires venipuncture at regular intervals of time causing anxiety and discomfort to the patient. Hence, development of a painless, non-invasive procedure is desirable for which saliva is a potential tool. Also, this would provide easy and cost-effective means for large scale screening and epidemiological intervention. Aim: To measure fasting plasma glucose (FPG) and compare and correlate with salivary glucose levels in normal and diabetic individuals. Also, the correlation between glycated hemoglobin (HbA1c) and salivary glucose is studied in the diabetics and controls. Methods: Blood and salivary glucose was estimated by GOD-POD method and glycated hemoglobin by HPLC. Statistical analysis was done on SPSS 16. Mean, Standard deviation, independent t test, ANOVA (f test), Pearson’s correlation coefficient along with regression analysis was carried out and comparison was done between the control and diabetic groups and the different subgroups within the diabetic group. Results: A significant difference between the salivary glucose levels in subjects indicating that a deranged glycemic status is reflected in saliva. Also, salivary glucose increases in proportion to an increase in the FPG and HbA1C of the diabetics. The regression coefficient was calculated and a formula was derived for prediction of FPG and HbA1c using salivary glucose. Conclusion: Saliva can be used as a screening tool for diabetes. Standardization of the technique and setting up a reference range will also make it useful in diagnosing diabetes mellitus.","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"30 1","pages":"145 - 152"},"PeriodicalIF":1.9,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88829997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信